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The Sternal IO and Vascular Access—Any Port in a Storm
Mark Vojtko, RN, BSN, CCRN, and Dan Hanfling, MD, FACEP
Attempting vascular access by out-of-hospital medical
providers is one of the most common and important inter-
ventions performed. Hypovolemia, hypothermia, obesity,
previous intravenous drug administration or abuse, burns,
and amputations complicate the establishment of venous ac-
cess. Failure rates have ranged between 10% and 40%1 and
have taken upward and beyond 25 minutes to establish.2
Such delays deprive a patient of intravenous fluids, volume
replacement, and medications and delay arrival at definitive
care. Delay in intravenous access and preceding interventions
are associated with higher morbidity and mortality rates.3 Es-
tablishing vascular access in 90 seconds, although widely
considered an operational goal of out-of-hospital providers, is
rarely achieved.
These concerns raise a fundamental issue with regard to
patient care and treatment: is it in the best interest of the
patient to “load and go,” performing interventions in the air
or ground unit under more difficult conditions, or should
secure vascular access be a must-have priority before initiat-
ing transport?
The FAST 1 intraosseous (IO) device has been recently de-
scribed in the air medical literature.4 This new adjunct for
achieving vascular access has proven beneficial for the follow-
ing reasons:
• Training is easy and takes a minimum of time. The skill
can be practiced repeatedly until a level of proficiency
has been achieved.
• Application of the device is quick, with average insertion
times of 77 seconds.2
• A high level of success (74%-95%) is achieved on first
attempts.2
• Event-to-door time is reduced.
• Patient outcomes improve when treated faster.
• A high level of safety is provided for both the user and
the patient.
• Situations for which the device is “not recommended”
are minimal.
Inova AirCare added the FAST 1 sternal IO to the cache of
equipment carried by flight crews. Our program is hospital
based, and each flight crew consists of a flight nurse and
flight paramedic. We perform approximately 40% scene and
60% interfacility transports. Flight nurse and paramedic
training in IO was based on the manufacturer’s training out-
line, video manual, and insertion simulator. We demonstrat-
ed full compliance and validated flight personnel skills before
adding the device. Existing medical protocols were revised to
reflect inclusion of the device as an adjunct for establishing
parenteral access.
Within 30 days of adding the IO to our program, the de-
vice was used in an extraordinary clinical situation that was
“not recommended” by the manufacturer. The flight crew de-
cided to place the sternal IO after all other options for obtain-
ing vascular access had been exhausted. Availability of the
sternal IO was essential to the ability of prehospital care
providers to deliver emergent care.
Flight Scenario
The patient was a 24-year-old man who had incurred
50%-60% third-degree burns to his abdomen, back, neck,
arms, and hands. The patient had driven himself to a nearby
residence for assistance, and the 9-1-1 system was activated.
The patient had poor recall of what had happened, but it
was suspected the patient had been fueling a hot equipment
item (ie, chainsaw or tractor). When the flight crew arrived,
the initial EMS responders had removed the patient’s cloth-
ing and placed him in dry sheets. They increased the med-
ical cabin temperature of their ambulance to aid in the pa-
tient’s thermoregulation and administered high-flow oxygen
by nonrebreather mask. Their attempts at peripheral IV ac-
cess and fluid administration were unsuccessful.
The flight crew found the patient awake but confused and
agitated. His airway initially was intact, but the flight crew
remained very concerned about the probability of inhalation
injury. Further attempts to achieve IV access in the patient’s
arms, neck, and lower extremities were unsuccessful (1-
18ga angiocatheter was placed in a hand, but it became in-
filtrated after fluid instillation). The crew strongly consid-
ered to placing a sternal IO at this time, but this option was
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deferred because of the manufacturer’s “not recommended”
guidelines in situations of impaired skin integrity.5
Given the patient’s extraordinary circumstances, the flight
nurse placed a 14-gauge, 3-inch angiocatheter in the femoral
vein on the first attempt and initiated fluid administration.
Our flight program does not routinely use central venous ac-
cess as a part of medical provision. However, under excep-
tional situations in which the patient’s condition is consid-
ered so critical that life or limb are immediately endangered,
such contingencies may be attempted.
Along with 0.9% normal saline infusing at a rapid rate to
gravity, a first round of sedatives and paralytic medications
(etomidate, vecuronium, and midazolam) were administered
through the femoral line in preparation for intubation be-
cause the patient’s airway became progressively compro-
mised. The patient became relaxed, appearing as if the med-
ications were achieving their desired effect. 
While the patient was being manually ventilated with a
bag-valve-mask, he suddenly sat up, became combative,
and rendered the femoral line unsuitable for use. The crew
presumed that the patient’s vascular depletion as a result of
his burn injuries may have altered the rate of drug delivery
and absorption. Furthermore, because femoral access was
performed with an angiocatheter, it is possible the adminis-
tered drugs may have extravasated into the surrounding
tissues.
With failed IV access, sedative and paralysis medications
administered with only partial effect, and a semiconscious
patient with a deteriorating airway, the next option was
placement of an IO needle in the medial malleolus. This was
performed, but it also failed. A second IO needle was placed
in the other ankle, and a good infusion rate was achieved. At
this time, the previously administered medications finally
took effect; the patient was successfully intubated, packaged,
and taken to the aircraft. The total scene time was approxi-
mately 55 minutes. Although extensive, what further compli-
cations might have occurred if the flight crew had quickly
“scooped and ran”?
In flight, the second IO needle began to fail. Given the
configuration of the Bell 412, the flight crew was unable to
safely reach and attempt to manipulate the failing IO nee-
dle. They decided to use the sternal IO, which they placed
easily and without complication. Placing the target patch al-
so was simple and straightforward, although this was a
night flight and added the additional difficulty of low-light
conditions and shadows. With the configuration of 1 atten-
dant at the patient’s head, aligning the introducer on the
target patch and applying pressure on the introducer for in-
sertion was excellent.
The approximate time to place the sternal IO and begin
fluid administration was less than 2 minutes. A good flow
rate by gravity of approximately 75 mL/hr was achieved. Fen-
tanyl and midazolam were given through the sternal IO line,
and a quick physiologic response was observed.
The remainder of the flight was uneventful. The patient
maintained cardiovascular stability and uncomplicated venti-
latory management. He was delivered to the regional burn
center, the receiving team was instructed on removal of the
device, and the removal tool (which is supplied with the in-
troducer, target patch, and protective dome) was secured to
the IV line attached to the sternal IO.
Multiple follow-up phone calls were made regarding this
patient. His burns were formally calculated at 54%. He was
progressing as expected with his therapies, with future surgi-
cal debridements pending. He remained mechanically venti-
lated but responded appropriately to commands. At 3 weeks,
there was no evidence of infection related to placing the ster-
nal IO on “impaired skin.” There were no reported difficulties
with removal of the device.
Conclusion
This case demonstrates one of the most difficult challenges
faced by providers in the out-of-hospital environment. Vas-
cular access remains a fundamental intervention that can in-
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fluence patient outcomes. In addition, safety is a paramount
issue for both the patient and the provider. Definitive mea-
sures must be performed, but a certain degree of patient con-
trol must be achieved before the actual transport can com-
mence. Given the prolonged scene time required for this
patient and the reliance on an extraordinary intervention that
fell outside the usual spectrum of care delivered under proto-
col, earlier use of the sternal IO may have expedited patient
transport. 
Further review and discussion on the use of such devices
will enhance the decision-making ability of out-of-hospital
providers for this mode under similar clinical circum-
stances.
The utility of the sternal IO as an adjunct to obtaining
vascular access has been demonstrated. Operational proto-
cols for its use should incorporate all manufacturer recom-
mendations and address additional exceptional considera-
tions for extraordinary situations, such as those reported
in this case. Impaired skin integrity from thermal injury,
severe lacerations, or pre-existing scarring should be re-
considered with respect to the indications for sternal IO
access. 
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When does deviation from treatment guidelines constitute
innovation in the standard of care? On 1 level, the decision
in the report by Vojtko and Hanfling to use a FAST 1 in-
traosseous access needle in a patient with extensive burns
can be viewed as clear deviation from the manufacturer’s
guidelines for use of their device. However, in the case de-
scribed, adequate vascular access could not be obtained by
other means, and the patient’s immediate condition was se-
verely compromised as a result. Consequently the para-
medics’ decision to use the FAST 1 before transport was in
the best interest of their patient and entirely logical. Further-
more, the clinical improvement achieved with volume re-
placement through the IO route, subsequent successful
transport to medical care, and the patient’s survival all sup-
port the validity of the decision. 
Fortunately, in spite of the skin over the sternum being se-
verely burned, there were no subsequent infectious complica-
tions at the insertion site, and staff at the receiving hospital
were able to remove the FAST 1 needle without difficulty.
Thus in this scenario, all the important outcomes were favor-
able. So on another level, “irregular” use of a FAST 1 device
can be seen as innovation.
Primum non nocere (first do no harm) is a legitimate cor-
nerstone in medical care. In consequence, most of the care
provided in an EMS prehospital context is protocol driven,
and medical oversight dialogue, where available, makes it
possible to extend or modify the treatment guidelines in
place. Because most protocols are carefully conceived and
evidence-based where possible, a process that monitors the
incidence and effect of protocol deviation is a valuable
quality assurance measure. 
Salerno,1 in a series of 1246 ALS ambulance calls, found
that 16% involved protocol deviations. Most of these devia-
tions occurred without dialogue or the consent of medical
control. Fifty-five percent of deviations were minor, 38%
were serious, and 7% were very serious. However, 89.5% of
these patients were unaffected by the deviations from proto-
cols, 5% actually improved, and 5.5% suffered complica-
tions, most of which were minor. Quality assurance of this
type is valuable and enables education to occur and con-
tributes to improvement of treatment guidelines where weak-
ness is evident in the existing protocols.2
In the air medical transport environment, some teams
have defined protocols, but most have treatment guidelines
with significant flexibility in decision-making. Consultation
with a physician overseeing the call is usually implicit in
their pattern of practice because most care provided consti-
tutes delegated medical acts. Sometimes circumstances are
such or a case sufficiently complex that thinking outside the
box and being innovative are essential for a patient to be
transported successfully. 
Strictly speaking (ie, from the standpoint of a transport
medical director), a physician should be consulted before
deviation from a protocol or device guideline occurs in each
individual case. Although such discussion affords important
medical and medicolegal support, it also must be recog-
nized that physician oversight itself may cause or contribute
to protocol deviation and errors of judgment.1 It is of
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greater relevance that during many transports dialogue with
a physician is not always feasible, and where the immediate
well-being of an actual patient is in jeopardy, the price of
innovation requires that we accept the element of risk asso-
ciated with irregular decisions made independently by
transport personnel. 
Clearly, such acceptance in no way endorses cavalier be-
havior or careless disregard for existing protocols, manu-
facturer’s guidelines regarding drugs and equipment, or
specific directives obtained from medical oversight. For de-
viation to be innovative, it is essential that the welfare of
the patient drives every decision and that each caregiver
acts entirely in the patient’s best interest. It is also neces-
sary that all the circumstances surrounding the deviation
are documented to limit liability3 and important to ensure
that what has occurred is shared fully in an educational
context.
Hippocrates4 could have been talking about air medical
transport when he said, “For extreme illnesses, extreme
treatments are most fitting.” Certainly this applies to the
case Vojtko and Hanfling report. However, it is important
that we share with our peers the failures as well as the suc-
cesses of cases involving irregular decisions. While it is
possible that only a small percentage of protocol deviations
are harmful,1 there is insufficient evidence in the literature
to be certain. 
Consequently, whether we call it quality assurance, re-
search, or the acquisition of data on which to base our prac-
tice, it is essential to learn the positive and negative lessons
from what is done and what is not done. Then, if we are truly
innovative, this process is followed by constructive change, as
following George Washington’s advice, “We weigh the pros
and cons and reason prevails.” In other words, thoughtful
and hopefully evidence-based review leads to improved
guidelines, protocols, medical oversight, and treatments that
enhance the quality and comprehensiveness of the care we
provide patients who require transport. 
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